GGrantIndex
Sort

39,280 grants matching leukemia

Molecular mechanism that suppresses the proliferation of cells with supernumerary centrioles

$422,076
Andrew Jon Holland · Johns Hopkins University · R01 · FY2021 · GM

Molecular mechanism that suppresses the proliferation of cells with supernumerary centrioles

$422,076
Brendan Patrick Cormack · Johns Hopkins University · R01 · FY2022 · GM

EASTERN COOPERATIVE ONCOLOGY GROUP

$422,042
Vanderbilt University · U10 · FY2001 · CA

Combinatorial Use of Anti-HIV RNA-based Therapeutics

$422,028
John Joseph Rossi · Beckman Research Institute/City Of Hope · R01 · FY2014 · AI

Combinatorial Use of Anti-HIV RNA-based Therapeutics

$422,028
John Joseph Rossi · Beckman Research Institute/City Of Hope · R01 · FY2012 · AI

Combinatorial Use of Anti-HIV RNA-based Therapeutics

$422,028
John Joseph Rossi · Beckman Research Institute/City Of Hope · R01 · FY2015 · AI

Role of the thymic epithelium on the outcome of allogeneic transplantation

$421,901
Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · AI

Role of the thymic epithelium on the outcome of allogeneic transplantation

$421,901
Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · AI

Role of the thymic epithelium on the outcome of allogeneic transplantation

$421,901
Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · AI

Training Program in Molecular Hematology

$421,888
Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2017 · HL

The structural function of ATR in development, oncogenesis and cancer therapy

$421,825
Shan Zha · Columbia University Health Sciences · R01 · FY2020 · CA

Control of Erythroid Cell Division and Differentiation

$421,807
Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2005 · HL

Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia

$421,762
Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA

The Role of Epigenetic Factors in Regulation of Coding and Non-Coding HOX Genes

$421,716
Alexander M Mazo · Ohio State University · P01 · FY2011 · CA

Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies

$421,711
Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$421,699
University Of Pennsylvania · U10 · FY2004 · CA

Targeting a Novel Secreted Immune Checkpoint to Enhance Liver Cancer Immunotherapy

$421,685
Yalan Deng · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA

Role of GAS41 in Human Cancer

$421,585
Xiaobing Shi · Van Andel Research Institute · R01 · FY2019 · CA

Tumor maintenance and development in mouse models

$421,514
Sloan-Kettering Institute For Cancer Res · U01 · FY2005 · CA

The Role of Epigenetic Factors in Regulation of Coding and Non-Coding HOX Genes

$421,468
Alexander M Mazo · Ohio State University · P01 · FY2012 · CA

Clinical Transplantation Exploiting NK Cell Activity

$421,429
Daniel J Weisdorf · University Of Minnesota · P01 · FY2011 · CA

Characterization of SLE-Susceptability Loci on Mouse Chromosome 1

$421,409
Laurence Morel · University Of Florida · R01 · FY2009 · AI

Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia

$421,375
Matthew S Davids · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Biology and Prognostic implications of Flt3 mutations in AML

$421,364
Soheil Meshinchi · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA

Control of Erythroid Differentiation by Transcription Elongation

$421,358
Leonard I Zon · Boston Children'S Hospital · P01 · FY2014 · HL